Dr. Craig Parks, a native Texan, earned a B.S. in Zoology at Texas Tech University, an MS in Zoology (Comparative Physiology emphasis) from The Ohio State University, and a Doctor of Veterinary Medicine, also from The Ohio State University. Dr. Parks’ science and research background includes environmental assessments for the Bureau of Land Management, as well as biomedical research with the Southwest Foundation for Research and Education. His experience in drug development includes more than three decades with entities such as Ohio State University, Novartis Animal Health and Lilly Elanco. Currently, Dr. Parks serves as the Vice President of Research and Development at Virbac.